$0.9600
0.007900.83%
At close: -
$0.9500
-0.01-1.04%
After Hours: 5:37 PM EDT
Comments
Loading...
Coherus BioSciences Stock Guidance | NASDAQ:CHRS | Benzinga
Coherus BioSciences issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 01/13/2025 | CHRS | Coherus BioSciences | FY | 2024 | — | — | — | $255.00M | $260.00M | $255.58M | Get Alert |
| 01/13/2025 | CHRS | Coherus BioSciences | Q4 | 2024 | — | — | — | $49.00M | $54.00M | $43.88M | Get Alert |
| 01/10/2024 | CHRS | Coherus BioSciences | Q4 | 2023 | — | — | — | $90.00M | — | $95.68M | Get Alert |
| 01/10/2024 | CHRS | Coherus BioSciences | FY | 2023 | — | — | — | $260.00M | $260.00M | $260.53M | Get Alert |
| 11/06/2023 | CHRS | Coherus BioSciences | FY | 2023 | — | — | — | $250.00M | $260.00M | $288.19M | Get Alert |
| 08/02/2023 | CHRS | Coherus BioSciences | FY | 2023 | — | — | — | $275.00M | — | $266.16M | Get Alert |
| 05/08/2023 | CHRS | Coherus BioSciences | FY | 2023 | — | — | — | $275.00M | — | $344.75M | Get Alert |
FAQ
What is the most recent guidance for Coherus BioSciences (CHRS)?
There have been no specific sales or earnings guidance reported for Coherus BioSciences in recent months.
Browse guidance and forecast on all stocks.